Biotx
2 known investors
biotx.ai applies large-scale Mendelian randomization and colocalization analysis across thousands of diseases and biomarkers to map causal relationships between genes and biological outcomes. The company uses this causally annotated genetic data and AI models trained on it to identify novel drug targets and improve clinical trial design for drug development.
AI & Machine LearningBiotechDeep Tech
Founders & leadership
JK
Joern KlingerinFounder · CEO2019–2025
Investors · 2
Frequently asked questions
- What does Biotx do?
- biotx.ai applies large-scale Mendelian randomization and colocalization analysis across thousands of diseases and biomarkers to map causal relationships between genes and biological outcomes. The company uses this causally annotated genetic data and AI models trained on it to identify novel drug targets and improve clinical trial design for drug development.
- Who founded Biotx?
- Biotx was founded by Joern Klinger.
- Who are Biotx's investors?
- Biotx's investors include Hoxton Ventures, Oxonian Ventures.